Toyama, Japan

Shingo Shimada

This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignee: Lead Chemical Company, Limited. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shingo Shimada. Retrieved from https://idiyas.com/inventor/shingo-shimada-fsfkogn9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shingo Shimada: Innovator in Cerebral Protection

Introduction

Shingo Shimada is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing innovative solutions for brain protection.

Latest Patents

Shimada holds a patent for a percutaneous absorption type cerebral protective agent. This agent contains 0.1 to 30 percent by mass of 3-methyl-1-phenyl-2-pyrazolin-5-one, or a medically acceptable salt thereof, in a base. The patent outlines the use of this compound as an active ingredient for manufacturing a pharmaceutical composition aimed at protecting the brain. Additionally, it describes a method of protecting the brain by administering this pharmaceutical composition to patients.

Career Highlights

Shingo Shimada is associated with Lead Chemical Company, Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in the field has led to advancements that could potentially improve patient outcomes in neurological health.

Collaborations

Shimada collaborates with talented individuals such as Jun Mori and Tamaki Horiuchi, contributing to a dynamic work environment that fosters innovation.

Conclusion

Shingo Shimada's work in developing a percutaneous absorption type cerebral protective agent showcases his commitment to advancing medical science. His contributions are vital in the ongoing quest to enhance brain health and protect against neurological damage.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…